Insider Transactions in Q2 2021 at Colgate Palmolive CO (CL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 10
2021
|
Kimberly A Nelson Director |
BUY
Grant, award, or other acquisition
|
Indirect |
1,799
+50.0%
|
-
|
|
May 10
2021
|
Martina Hundmejean Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+36.35%
|
-
|
|
May 10
2021
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+8.82%
|
-
|
|
May 10
2021
|
Lisa Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,620
+23.97%
|
-
|
|
May 10
2021
|
Stephen I Sadove Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,159
+9.79%
|
-
|
|
May 10
2021
|
Michael B Polk Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+9.56%
|
-
|
|
May 10
2021
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+9.64%
|
-
|
|
May 10
2021
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,620
+9.96%
|
-
|
|
May 10
2021
|
John T Cahill Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,159
+7.83%
|
-
|
|
May 10
2021
|
Sally Massey Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
5,733
-42.15%
|
$475,839
$83.67 P/Share
|
|
May 10
2021
|
Sally Massey Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,733
+29.65%
|
$412,776
$72.99 P/Share
|
|
May 10
2021
|
Jennifer Daniels CLO and Secretary |
SELL
Open market or private sale
|
Direct |
20,289
-33.48%
|
$1,663,698
$82.62 P/Share
|
|
May 10
2021
|
Jennifer Daniels CLO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
20,289
+25.08%
|
$1,460,808
$72.99 P/Share
|
|
May 06
2021
|
John W Kooyman Chief of Staff |
SELL
Open market or private sale
|
Direct |
11,195
-58.15%
|
$917,990
$82.07 P/Share
|
|
May 06
2021
|
John W Kooyman Chief of Staff |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+34.19%
|
$610,000
$61.93 P/Share
|
|
May 05
2021
|
John P Bilbrey Director |
SELL
Open market or private sale
|
Direct |
3,941
-17.89%
|
$315,280
$80.95 P/Share
|
|
May 05
2021
|
John P Bilbrey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,652
+17.44%
|
$311,684
$67.83 P/Share
|
|
May 05
2021
|
Patricia Verduin SVP, Global Technology |
SELL
Open market or private sale
|
Direct |
46,566
-46.25%
|
$3,725,280
$80.89 P/Share
|
|
May 05
2021
|
Patricia Verduin SVP, Global Technology |
BUY
Exercise of conversion of derivative security
|
Direct |
46,566
+31.62%
|
$2,840,526
$61.93 P/Share
|
|
May 05
2021
|
Noel R. Wallace Chairman, President & CEO |
SELL
Open market or private sale
|
Direct |
25,279
-9.83%
|
$2,047,599
$81.03 P/Share
|
|
May 05
2021
|
Noel R. Wallace Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,279
+8.95%
|
$1,542,019
$61.93 P/Share
|
|
May 05
2021
|
Stephen I Sadove Director |
SELL
Open market or private sale
|
Indirect |
8,000
-31.08%
|
$648,000
$81.3 P/Share
|
|
Apr 01
2021
|
John P Bilbrey Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+1.3%
|
$17,328
$76.48 P/Share
|
|
Apr 01
2021
|
Helene D Gayle Director |
BUY
Grant, award, or other acquisition
|
Direct |
228
+1.07%
|
$17,328
$76.48 P/Share
|
|
Apr 01
2021
|
Lorrie M Norrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
212
+1.04%
|
$16,112
$76.48 P/Share
|